Steven Pincuss

Steven Pincuss

Company: Neurogene

Job title: Executive Director, Analytical Development


Analytical Development Challenges with AAV Treatments for Ultra-rare Diseases 11:30 am

Developing Analytical specifications for clinical and commercial lots is challenging due to the minimum number of lots that may be produced during an ultra-rare disease program The function of the defective gene in ultra-rare diseases may not be known Potency assays therefore may be based on a matrix approachRead more

day: Track A - Day 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.